Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Apr;48(1):261–267.

The action of Clofazimine on the level of lysosomal enzymes of cultured macrophages.

J Sarracent, C M Finlay
PMCID: PMC1536573  PMID: 7083642

Abstract

Mouse peritoneal and calf alveolar macrophage cultures were exposed to various concentrations of Clofazimine, 3 (p-chloroanilino)-10-p-Chlorophenyl 2, 10-dihydro-2-isopropylimino, for 120 hr and an increase of four lysosomal enzymes were found with 0 . 3 micrograms/ml of the drug. In mouse peritoneal macrophage cultures, higher concentrations were toxic. Cycloheximide inhibited the lysosomal enzyme activity increase found. No change in enzymatic activity was observed when a lysosomal enriched granular fraction was incubated with various drug concentrations. Our results strongly suggest that Clofazimine at concentrations close to therapeutic serum levels induces de novo synthesis of lysosomal enzymes in macrophage cultures.

Full text

PDF
264

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banerjee D. K., Ellard G. A., Gammon P. T., Waters M. F. Some observations on the pharmacology of clofazimine (B663). Am J Trop Med Hyg. 1974 Nov;23(6):1110–1115. doi: 10.4269/ajtmh.1974.23.1110. [DOI] [PubMed] [Google Scholar]
  2. Barrett A. J. A new assay for cathepsin B1 and other thiol proteinases. Anal Biochem. 1972 May;47(1):280–293. doi: 10.1016/0003-2697(72)90302-8. [DOI] [PubMed] [Google Scholar]
  3. Brandt L. Enhancing effect of clofazimine (B663) on the phagocytosis of neutrophilic leucocytes in vitro. Scand J Haematol. 1971;8(4):265–269. doi: 10.1111/j.1600-0609.1971.tb00874.x. [DOI] [PubMed] [Google Scholar]
  4. Brandt L., Svensson B. Stimulation of macrophage phagocytosis by clofazimine. Scand J Haematol. 1973;10(4):261–264. doi: 10.1111/j.1600-0609.1973.tb00070.x. [DOI] [PubMed] [Google Scholar]
  5. COHN Z. A., BENSON B. THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES. MORPHOLOGY, CYTOCHEMISTRY, AND BIOCHEMISTRY. J Exp Med. 1965 Jan 1;121:153–170. doi: 10.1084/jem.121.1.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. CONCHIE J., FINDLAY J., LEVVY G. A. Mammalian glycosidases; distribution in the body. Biochem J. 1959 Feb;71(2):318–325. doi: 10.1042/bj0710318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cline M. J. Drug potentiation of macrophage function. Infect Immun. 1970 Nov;2(5):601–605. doi: 10.1128/iai.2.5.601-605.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davies P., Krakauer K., Weissmann G. Subcellular distribution of neutral protease and peptidases in rabbit polymorphonuclear leucocytes. Nature. 1970 Nov 21;228(5273):761–762. doi: 10.1038/228761a0. [DOI] [PubMed] [Google Scholar]
  9. Einstein L. P., Schneeberger E. E., Colten H. R. Synthesis of the second component of complement by long-term primary cultures of human monocytes. J Exp Med. 1976 Jan 1;143(1):114–126. doi: 10.1084/jem.143.1.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Finlay C., Davies P., Allison A. C. Changes in cellular enzyme levels and the inhibition of selective release of lysosomal hydrolases from macrophages by indomethacin. Agents Actions. 1975 Oct;5(4):345–353. doi: 10.1007/BF02205241. [DOI] [PubMed] [Google Scholar]
  11. GOLDBARG J. A., RUTENBURG A. M. The colorimetric determination of leucine aminopeptidase in urine and serum of normal subjects and patients with cancer and other diseases. Cancer. 1958 Mar-Apr;11(2):283–291. doi: 10.1002/1097-0142(195803/04)11:2<283::aid-cncr2820110209>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  12. KISSANE J. M., ROBINS E. The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem. 1958 Jul;233(1):184–188. [PubMed] [Google Scholar]
  13. Karnovsky M. L., Lazdins J., Drath D., Harper A. Biochemical characteristics of activated macrophages. Ann N Y Acad Sci. 1975 Jun 13;256:266–274. doi: 10.1111/j.1749-6632.1975.tb36053.x. [DOI] [PubMed] [Google Scholar]
  14. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  15. Levy L. Pharmacologic studies of clofazimine. Am J Trop Med Hyg. 1974 Nov;23(6):1097–1109. doi: 10.4269/ajtmh.1974.23.1097. [DOI] [PubMed] [Google Scholar]
  16. MYRVIK Q., LEAKE E. S., FARISS B. Studies on pulmonary alveolar macrophages from the normal rabbit: a technique to procure them in a high state of purity. J Immunol. 1961 Feb;86:128–132. [PubMed] [Google Scholar]
  17. Michaëlsson G., Molin L., Ohmann S., Gip L., Lindström B., Skogh M., Trolin I. Clofazimine. A new agent for the treatment of pyoderma gangrenosum. Arch Dermatol. 1976 Mar;112(3):344–349. [PubMed] [Google Scholar]
  18. Molin L. Clofazimine-enhanced phagocytosis in pustulosis palmaris et plantaris. Acta Derm Venereol. 1975;55(2):151–153. [PubMed] [Google Scholar]
  19. OREN R., FARNHAM A. E., SAITO K., MILOFSKY E., KARNOVSKY M. L. Metabolic patterns in three types of phagocytizing cells. J Cell Biol. 1963 Jun;17:487–501. doi: 10.1083/jcb.17.3.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. WOOLLEN J. W., HEYWORTH R., WALKER P. G. Studies on glucosaminidase. 3. Testicular N-acetyl-beta-glucosaminidase and N-acetyl-beta-galactosaminidase. Biochem J. 1961 Jan;78:111–116. doi: 10.1042/bj0780111. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES